Medivir AB (LTS:0GP7)
kr 2.73 -0.19669 (-6.72%) Market Cap: 302.85 Mil Enterprise Value: 146.87 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 58/100

Q2 2023 Medivir AB Earnings Call Transcript

Aug 18, 2023 / 12:00PM GMT
Release Date Price: kr7
Operator

Welcome to the Medivir Q2 report 2023. (Operator Instructions) Now, I will hand the conference over to CEO, Jens Lindberg. Please go ahead.

Jens Lindberg
Medivir AB - CEO

Thank you, and welcome, everyone, logging in or dialing in to this webcast, a Friday afternoon webcast, not usually the day we run this. But hopefully, we can close out the week with a good session. We have had quite an eventful quarter at Medivir, and we are at a very exciting time for the company and for our lead program, fostrox, in liver cancer. And we very much look forward to sharing more details in the webcast today as we move forward.

So we were planning to be four today; we will be three. We are missing our CMO, Pia, today. She has actually come down with cold and a fever. And most importantly, she has lost her voice. So you are going to have to make do with us today. And unfortunately, that means you will need to hear a lot from me during the session today.

Important information, I will not go through it in detail. We'll be -- you will find our presentation on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot